IBANDRONATE SODIUM
UNII J12U072QL0

Substance Identification & Data

This profile provides standardized clinical and technical data for Ibandronate Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J12U072QL0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 138926-19-9 and the RxNorm Concept ID (RxCUI) 236916. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

J12U072QL0

CAS Registry Number

138926-19-9

RxNorm Concept ID

236916

Detailed Substance Profile

Preferred Name

IBANDRONATE SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

J12U072QL0

The specific atomic composition represented as a molecular structure string.

InChIKey

C9H22NO7P2.Na.H2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VBDRTGFACFYFCT-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1670

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23663991

Unique identification number in the NCBI database of chemical substances.

USAN ID

JJ-78

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(CCN(CCCCC)C)(O)(P(O)([O-])=O)P(O)(O)=O.O.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ibandronate Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.